Somnomed Limited (AU:SOM) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Somnomed Limited announced a change in the indirect interest of its director, Benjamin Gisz, who acquired 300,000 options in addition to his existing 67,716,079 ordinary shares. This acquisition was approved at the company’s Annual General Meeting and reflects a strategic move by TDM Growth Partners Pty Ltd, which controls the disposal of client shareholdings in SomnoMed.
For further insights into AU:SOM stock, check out TipRanks’ Stock Analysis page.